{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:30:30Z","timestamp":1792650630375,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21602196"],"award-info":[{"award-number":["21602196"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31760226"],"award-info":[{"award-number":["31760226"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31960075"],"award-info":[{"award-number":["31960075"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018531","name":"Major Science and Technology Projects in Yunnan Province","doi-asserted-by":"publisher","award":["2017FG001-046"],"award-info":[{"award-number":["2017FG001-046"]}],"id":[{"id":"10.13039\/501100018531","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018531","name":"Major Science and Technology Projects in Yunnan Province","doi-asserted-by":"publisher","award":["2017ZF003"],"award-info":[{"award-number":["2017ZF003"]}],"id":[{"id":"10.13039\/501100018531","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.cbi.2022.110084","type":"journal-article","created":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T10:58:15Z","timestamp":1660301895000},"page":"110084","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Dimeric-(\u2212)-epigallocatechin-3-gallate inhibits the proliferation of lung cancer cells by inhibiting the EGFR signaling pathway"],"prefix":"10.1016","volume":"365","author":[{"given":"Xiu-Li","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-Min","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Rong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Xia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Long","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan-Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Ting","family":"Zi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2022.110084_bib1","first-page":"7","article-title":"Cancer statistics","volume":"71","author":"Siegel","year":"2021","journal-title":"Ca - Cancer J. Clin."},{"key":"10.1016\/j.cbi.2022.110084_bib2","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1158\/1078-0432.CCR-09-0109","article-title":"The green tea polyphenol EGCG potentiates the antiproliferative activity of c-Met and epidermal growth factor receptor inhibitors in non-small cell lung cancer cells","volume":"15","author":"Milligan","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cbi.2022.110084_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/1078155216682365","article-title":"Necitumumab for the treatment of squamous cell non-small cell lung cancer","volume":"24","author":"Brinkmeyer","year":"2018","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.cbi.2022.110084_bib4","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1158\/1055-9965.EPI-20-0865","article-title":"Biomarkers for lung cancer screening and detection","volume":"29","author":"Ostrin","year":"2020","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.cbi.2022.110084_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9072255","article-title":"ErBb family proteins in cholangiocarcinoma and clinical implications","volume":"9","author":"Jin","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cbi.2022.110084_bib6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2174\/1389450053765879","article-title":"The ErbB receptors and their ligands in cancer: an overview","volume":"6","author":"Normanno","year":"2005","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.cbi.2022.110084_bib7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1742-4658.2009.07449.x","article-title":"Epidermal growth factor receptor in relation to tumor development: EGFR-targeted anticancer therapy","volume":"277","author":"Okamoto","year":"2010","journal-title":"FEBS J."},{"key":"10.1016\/j.cbi.2022.110084_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143515","article-title":"Molecular epidemiology of EGFR mutations in asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology - mainland China subset analysis of the PIONEER study","volume":"10","author":"Shi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2022.110084_bib9","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1007\/s00018-020-03686-6","article-title":"Gefitinib induces EGFR and alpha5beta1 integrin co-endocytosis in glioblastoma cells","volume":"78","author":"Blandin","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cbi.2022.110084_bib10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s13402-020-00576-8","article-title":"Tweaking EMT and MDR dynamics to constrain triple-negative breast cancer invasiveness by EGFR and Wnt\/beta-catenin signaling regulation","volume":"44","author":"Shome","year":"2021","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.cbi.2022.110084_bib11","author":"Akamatsu","year":"2021"},{"key":"10.1016\/j.cbi.2022.110084_bib12","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.1038\/s41388-021-01962-8","article-title":"NDRG1 enhances the sensitivity of cetuximab by modulating EGFR trafficking in colorectal cancer","volume":"40","author":"Yang","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.cbi.2022.110084_bib13","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/CEJ.0000000000000464","article-title":"Genetic polymorphism of catechol-O-methyltransferase modulates the association of green tea consumption and lung cancer","volume":"28","author":"Lai","year":"2019","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.cbi.2022.110084_bib14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jnutbio.2016.12.004","article-title":"EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivo via down-regulation of NF-kappaB and MMP-9","volume":"41","author":"Luo","year":"2017","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.cbi.2022.110084_bib15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.taap.2006.11.024","article-title":"Tea and cancer prevention: molecular mechanisms and human relevance","volume":"224","author":"Yang","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2022.110084_bib16","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1080\/13543776.2016.1203419","article-title":"Therapeutic effects of EGCG: a patent review","volume":"26","author":"Chakrawarti","year":"2016","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.cbi.2022.110084_bib17","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3892\/or.2013.2933","article-title":"Epigallocatechin gallate inhibits the growth of human lung cancer by directly targeting the EGFR signaling pathway","volume":"31","author":"Ma","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.cbi.2022.110084_bib18","series-title":"Antioxidant Activity of O-Protected Derivatives of (-)-epigallocatechin-3- Gallate: Inhibition of Soybean and Rabbit 15-lipoxygenases","first-page":"2007","author":"Utenova","year":"2007"},{"key":"10.1016\/j.cbi.2022.110084_bib19","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1038\/s41598-017-05457-z","article-title":"Hydrogen sulfide acts as a double-edged sword in human hepatocellular carcinoma cells through EGFR\/ERK\/MMP-2 and PTEN\/AKT signaling pathways","volume":"7","author":"Wu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2022.110084_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113923","article-title":"The inhibitory effect of ECG and EGCG dimeric procyanidins on colorectal cancer cells growth is associated with their actions at lipid rafts and the inhibition of the epidermal growth factor receptor signaling","volume":"175","author":"Zhu","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2022.110084_bib21","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.cbi.2022.110084_bib22","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1128\/MCB.00742-10","article-title":"Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor","volume":"30","author":"Lu","year":"2010","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.cbi.2022.110084_bib23","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/jcc.21396","article-title":"A new force field for simulating phosphatidylcholine bilayers","volume":"31","author":"Poger","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.cbi.2022.110084_bib24","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00249-011-0700-9","article-title":"Definition and testing of the GROMOS force-field versions 54A7 and 54B7","volume":"40","author":"Schmid","year":"2011","journal-title":"Eur. Biophys. J."},{"key":"10.1016\/j.cbi.2022.110084_bib25","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.bbapap.2016.03.017","article-title":"Role of dietary antioxidant (-)-epicatechin in the development of beta-lactoglobulin fibrils","volume":"1864","author":"Carbonaro","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2022.110084_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.06.028","article-title":"Molecular dynamics simulations of the interaction of Mouse and Torpedo acetylcholinesterase with covalent inhibitors explain their differential reactivity: implications for drug design","volume":"310","author":"Chandar","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2022.110084_bib27","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"Source Drug Discovery, A. Lynn, g_mmpbsa--a GROMACS tool for high-throughput MM-PBSA calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.cbi.2022.110084_bib28","first-page":"1","article-title":"Identification of natural inhibitors against Mpro of SARS-CoV-2 by molecular docking, molecular dynamics simulation, and MM\/PBSA methods","author":"Sharma","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.cbi.2022.110084_bib29","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.tet.2011.01.030","article-title":"Pd(DPEPhos)Cl2-catalyzed Negishi cross-couplings for the formation of biaryl and diarylmethane phloroglucinol adducts","volume":"67","author":"De Nnis","year":"2011","journal-title":"Tetrahedron"},{"key":"10.1016\/j.cbi.2022.110084_bib30","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1271\/bbb.66.1764","article-title":"Synthetic studies of proanthocyanidins. Highly stereoselective synthesis of the catechin dimer, procyanidin-B3","volume":"66","author":"Saito","year":"2002","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.cbi.2022.110084_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111833","article-title":"Effect of epigallocatechin-3-gallate on EGFR signaling and migration in non-small cell lung cancer","volume":"22","author":"Minnelli","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2022.110084_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/md18110545","article-title":"Recent Advances in Molecular Docking for the Research and Discovery of Potential Marine Drugs","volume":"vol. 18","author":"Chen","year":"2020","journal-title":"Mar Drugs"},{"key":"10.1016\/j.cbi.2022.110084_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodhyd.2020.105824","article-title":"Inhibitory mechanism of vitexin on \u03b1-glucosidase and its synergy with acarbose","volume":"105","author":"Ni","year":"2020","journal-title":"Food Hydrocolloids"},{"key":"10.1016\/j.cbi.2022.110084_bib34","article-title":"Synthesis, molecular docking, molecular dynamics, DFT and antimicrobial activity studies of 5-substituted-2-(p -methylphenyl)benzoxazole derivatives","volume":"1234","author":"Me","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.cbi.2022.110084_bib35","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.2147\/OTT.S159612","article-title":"EGFR, KRAS, BRAF, PTEN, and PIK3CA mutation in plasma of small cell lung cancer patients","volume":"11","author":"Lu","year":"2018","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.cbi.2022.110084_bib36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12890-019-0964-x","article-title":"EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma","volume":"19","author":"Colombino","year":"2019","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.cbi.2022.110084_bib37","first-page":"1545","article-title":"Daily or weekly dosing with EGFR inhibitors, gefitinib and lapatinib, and AKt inhibitor MK2206 in mammary cancer models","volume":"40","author":"Lubet","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.cbi.2022.110084_bib38","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.jtho.2017.08.006","article-title":"Combination osimertinib and gefitinib in C797S and T790M EGFR-mutated non-small cell lung cancer","volume":"12","author":"Arulananda","year":"2017","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.cbi.2022.110084_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110186","article-title":"A review for physiological activities of EGCG and the role in improving fertility in humans\/mammals","volume":"127","author":"Zhang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2022.110084_bib40","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4103\/0973-1296.204546","article-title":"Anti-fatigue effect of green tea polyphenols (-)-Epigallocatechin-3-Gallate (EGCG)","volume":"13","author":"Teng","year":"2017","journal-title":"Phcog. Mag."},{"key":"10.1016\/j.cbi.2022.110084_bib41","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.2147\/OTT.S209441","article-title":"EGCG overcomes gefitinib resistance by inhibiting autophagy and augmenting cell death through targeting ERK phosphorylation in NSCLC","volume":"12","author":"Meng","year":"2019","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.cbi.2022.110084_bib42","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/carcin\/bgq039","article-title":"Pro-oxidative activities and dose-response relationship of (-)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitro","volume":"31","author":"Li","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cbi.2022.110084_bib43","article-title":"Novel perbutyrylated glucose derivatives of (-)-Epigallocatechin-3-Gallate inhibit cancer cells proliferation by decreasing phosphorylation of the EGFR: synthesis, cytotoxicity, and molecular docking","volume":"26","author":"Wang","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2022.110084_bib44","article-title":"Challenge and countermeasures for EGFR targeted therapy in non-small cell lung cancer","volume":"1877","author":"Tian","year":"2022","journal-title":"Biochim. Biophys. Acta Rev. Canc"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279722002897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279722002897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:52:31Z","timestamp":1762113151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279722002897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":44,"alternative-id":["S0009279722002897"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2022.110084","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dimeric-(\u2212)-epigallocatechin-3-gallate inhibits the proliferation of lung cancer cells by inhibiting the EGFR signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2022.110084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110084"}}